There is no physiological reason you cannot alternate between protocols
3,19,20 They stimulate satiety , the sense of feeling full after a meal, reducing cravings and caloric intake.GLP-1 agonists are approved for use in some people with type II diabetes, and two of them are FDA-approved for weight loss in certain people and situations
Pieralice et al., 2025), demonstrating that therapeutic targeting of the metabolic axis is effective
That logic is self-defeating: If GLP-1s really are worth that much to Americans health, then they are worth paying the market price and worth enough that other suppliers will want to introduce competitors to meet Americans needs
Grasset, E
CRP is an acute-phase protein that reflects systemic inflammation and is strongly linked to insulin resistance Some early evidence suggests that GLP-1 receptor agonists may affect cognitive function by influencing neurotransmitter activity and reducing inflammation in the brain